Modified T cell receptors and related materials and methods
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 3, 2012
Grant Date -
Feb 11, 2010
app pub date -
Sep 26, 2007
filing date -
Sep 26, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
T cells. Polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, and pharmaceutical compositions related to the modified TCR also are part of the invention. Further, the invention is directed to methods of detecting a diseased cell in a host, methods of treating or preventing a disease in a host, and methods of identifying a candidate adoptive immunotherapy TCR.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully